These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33826771)

  • 1. Diabetes technologies in people with type 1 diabetes mellitus and disordered eating: A systematic review on continuous subcutaneous insulin infusion, continuous glucose monitoring and automated insulin delivery.
    Priesterroth L; Grammes J; Clauter M; Kubiak T
    Diabet Med; 2021 Jul; 38(7):e14581. PubMed ID: 33826771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the traditional Chinese version of the diabetes eating problem survey-revised and study of the prevalence of disordered eating patterns in Chinese patients with type 1 DM.
    Lok CW; Wong MC; Yip KW; Ching WK; Choi EKY
    BMC Psychiatry; 2023 May; 23(1):382. PubMed ID: 37259043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review.
    Alvarenga CS; La Banca RO; Neris RR; de Cássia Sparapani V; Fuentealba-Torres M; Cartagena-Ramos D; Leal CL; Esper MV; Nascimento LC
    BMC Endocr Disord; 2022 Feb; 22(1):43. PubMed ID: 35183150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Type 1 Diabetes Mellitus and Eating Disorders: A Systematic Review and Meta-Analysis.
    Dean YE; Motawea KR; Aslam M; Pintado JJL; Popoola-Samuel HAO; Salam M; Dundi POR; Donaldy W; Aledani EM; Alqiqie Z; Sultana N; Mohamed ARH; Elalem A; Syeda STH; Mohamed MS; Assal MW; Attia NM; Hagar H; Abdelaziz HA; Subedi A; Elbahaie A; Hazimeh Y; Aiash H
    Endocrinol Diabetes Metab; 2024 May; 7(3):e473. PubMed ID: 38597269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence with no gender difference of likely eating disorders in type 1 mellitus diabetes on insulin pump.
    Albaladejo L; Périnet-Marquet P; Buis C; Lablanche S; Iceta S; Arnol N; Logerot S; Borel JC; Bétry C
    Diabetes Res Clin Pract; 2023 May; 199():110630. PubMed ID: 36934794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parents' experiences on the combined use of continuous subcutaneous insulin infusion and real-time continuous glucose monitoring to manage Type 1 diabetes in their children: A systematic review and meta-synthesis of qualitative studies.
    Luo X; Pan J; Lu H; Li X
    Nurs Open; 2022 Nov; 9(6):2532-2551. PubMed ID: 34191399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disordered eating and insulin restriction in type 1 diabetes: A systematic review and testable model.
    De Paoli T; Rogers PJ
    Eat Disord; 2018; 26(4):343-360. PubMed ID: 29182474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Dicembrini I; Mannucci E; Monami M; Pala L
    Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.
    Rigo RS; Levin LE; Belsito DV; Garzon MC; Gandica R; Williams KM
    J Diabetes Sci Technol; 2021 Jul; 15(4):786-791. PubMed ID: 32389062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
    Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N
    Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disordered eating behaviors in youth with type 1 diabetes: prospective pilot assessment following initiation of insulin pump therapy.
    Markowitz JT; Alleyn CA; Phillips R; Muir A; Young-Hyman D; Laffel LM
    Diabetes Technol Ther; 2013 May; 15(5):428-33. PubMed ID: 23550556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disordered eating behaviour in adolescents with type 1 diabetes on continuous subcutaneous insulin infusion; relation to body image, depression and glycemic control.
    Salah NY; Hashim MA; Abdeen MSE
    J Eat Disord; 2022 Apr; 10(1):46. PubMed ID: 35379350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of continuous subcutaneous insulin infusion and continuous glucose monitoring systems in the Community of Madrid].
    Arranz Martín A; Calle Pascual A; Del Cañizo Gómez FJ; González Albarrán O; Lisbona Gil A; Botella Serrano M; Pallardo Sánchez LF;
    Endocrinol Nutr; 2015 Apr; 62(4):171-9. PubMed ID: 25726367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.